ATE451618T1 - Verfahren zur identifizierung von epitopen in zusammenhang mit immunogenität bei biopharmazeutika - Google Patents

Verfahren zur identifizierung von epitopen in zusammenhang mit immunogenität bei biopharmazeutika

Info

Publication number
ATE451618T1
ATE451618T1 AT06112423T AT06112423T ATE451618T1 AT E451618 T1 ATE451618 T1 AT E451618T1 AT 06112423 T AT06112423 T AT 06112423T AT 06112423 T AT06112423 T AT 06112423T AT E451618 T1 ATE451618 T1 AT E451618T1
Authority
AT
Austria
Prior art keywords
apr
peptides
immunogenicity
immunogenic
identifying
Prior art date
Application number
AT06112423T
Other languages
English (en)
Inventor
Harald Kropshofer
Anne Vogt
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE451618T1 publication Critical patent/ATE451618T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
AT06112423T 2005-04-20 2006-04-10 Verfahren zur identifizierung von epitopen in zusammenhang mit immunogenität bei biopharmazeutika ATE451618T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05103199 2005-04-20

Publications (1)

Publication Number Publication Date
ATE451618T1 true ATE451618T1 (de) 2009-12-15

Family

ID=37114190

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06112423T ATE451618T1 (de) 2005-04-20 2006-04-10 Verfahren zur identifizierung von epitopen in zusammenhang mit immunogenität bei biopharmazeutika

Country Status (8)

Country Link
US (1) US20060251664A1 (de)
JP (1) JP4275144B2 (de)
CN (1) CN1877336A (de)
AT (1) ATE451618T1 (de)
CA (1) CA2542104C (de)
DE (1) DE602006010934D1 (de)
ES (1) ES2334936T3 (de)
SG (1) SG126893A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5331714B2 (ja) * 2007-03-16 2013-10-30 コヴァルクス・アーゲー タンパク質複合体をターゲティングする薬物候補の直接質量分析
CN102625832A (zh) 2009-08-24 2012-08-01 贝勒医学院 产生对多种肿瘤抗原或多种病毒特异的ctl细胞系
GB201121308D0 (en) 2011-12-12 2012-01-25 Cell Medica Ltd Process
ES2748652T3 (es) 2012-02-09 2020-03-17 Baylor College Medicine Mezclas pep para generar CTL multivíricos con amplia especificidad
EP3170901B1 (de) * 2014-07-14 2021-06-02 Chugai Seiyaku Kabushiki Kaisha Verfahren zur produktion dendritischer zellen aus stammzellen
EP3350600A4 (de) * 2015-09-18 2019-04-17 Baylor College of Medicine Unterscheidung eines immunogenen antigens von einem pathogen und korrelation mit klinischer wirksamkeit
WO2018189148A1 (en) 2017-04-10 2018-10-18 Immatics Biotechnologies Gmbh Peptides and combination thereof for use in the immunotherapy against cancers
BR112019020959A2 (pt) 2017-04-10 2020-05-05 Immatics Biotechnologies Gmbh peptídeos e combinações dos mesmos para uso na imunoterapia contra câncer
AU2019269641A1 (en) * 2018-05-17 2020-12-03 Immunome, Inc. CH3 domain epitope tags
JP2022155547A (ja) * 2021-03-30 2022-10-13 ミナリスメディカル株式会社 蛋白質が結合したラテックス粒子の安定化方法
WO2024138754A1 (zh) * 2022-12-30 2024-07-04 深圳吉诺因生物科技有限公司 一种hla-a*11:01限制性抗原点替换方法、获得的多肽及其应用
AU2024266326A1 (en) * 2023-05-03 2025-11-13 Immunoracle Inc. Compositions and methods of analyzing a sample for antigen-specific immune cells

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1405862B1 (de) * 2002-10-02 2008-04-09 F.Hoffmann-La Roche Ag Verfahren zur Identifizierung antigener Peptide

Also Published As

Publication number Publication date
CA2542104A1 (en) 2006-10-20
US20060251664A1 (en) 2006-11-09
JP4275144B2 (ja) 2009-06-10
SG126893A1 (en) 2006-11-29
DE602006010934D1 (de) 2010-01-21
CN1877336A (zh) 2006-12-13
JP2006300945A (ja) 2006-11-02
CA2542104C (en) 2010-12-07
ES2334936T3 (es) 2010-03-17

Similar Documents

Publication Publication Date Title
WO2004063963A3 (en) Novel proteins with altered immunogenicity
CY1120822T1 (el) Διαειδικα ειδικη επικρατεια δεσμευσης
MX337456B (es) Vacunas peptidicas para canceres que expresan antigenos asociados con tumores.
WO2007064919A3 (en) Binding polypeptides with restricted diversity sequences
UA110599C2 (uk) Пептид для імунотерапії пухлин, включаючи нейрональні пухлини та пухлини мозку
ATE521708T1 (de) Chimärische, hybrid- und tandem-polypeptide von meningococcus nmb1870
ATE451618T1 (de) Verfahren zur identifizierung von epitopen in zusammenhang mit immunogenität bei biopharmazeutika
TW200515916A (en) Chimeric antigens for breaking host tolerance to foreign antigens
MX2014005546A (es) Anticuerpos de union de albumina y fragmentos de union de los mismos.
WO2006046978A3 (en) Cationic peptide-mediated transformation
DE60139542D1 (de) Methoden zur herstellung humaner monoklonaler antikörper
SI2163562T1 (sl) IL-1 beta vezavna protitelesa in njihovi fragmenti
MX361076B (es) Proteínas multifunción que comprenden complejo mayor de histocompatibilidad (cmh) de clase i multivalente unido mediante disulfuro.
WO2007146401A3 (en) Denatured collagen peptides and uses thereof
ES2531142T3 (es) Péptidos WT1 de unión a HLA de clase II, y composiciones y métodos que los comprenden
WO2011022077A3 (en) A nucleic acid cassette for producing recombinant antibodies
EP4269562A3 (de) Antigenbindende moleküle und verfahren zur verwendung davon
WO2005012531A3 (en) Antibody cdr polypeptide sequences with restricted diversity
DE602005021379D1 (de) System und verfahren zur produktion von antikörpern in der pflanzenzellkultur
MY148646A (en) Anti-psgl-1 antibodies
WO2014144911A3 (en) Hybrid immunoglobulin containing non-peptidyl linkage
NZ609916A (en) Hla-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof
WO2008010098A3 (en) Identification, optimization and use of cryptic hla-b7 epitopes for immunotherapy
WO2006134190A8 (es) Agentes y métodos basados en el uso del dominio eda de la fibronectina
MX2010000232A (es) Metodos mejorados para la formacion de enlaces disulfuro.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties